ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2025
Management of Thyroid Hurthle Cell Carcinoma: A Single Centre Analysis.
Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hurthle cell carcinoma (HCC) is a rare neoplasm of the thyroid gland. There is paucity of medical literature available on this histological subtype compared to other thyroid disease and thus no consensus on optimal treatment. We conducted a single centre retrospective analysis of histologically diagnosed patients with HCC to demonstrate management of these cases and rate of recurrence. Data were collected for patients who were diagnosed with HCC between 2010 and 2022 in East Kent Hospitals University NHS Trust, UK. Our results found 8 patients diagnosed with HCC (2M:6F) with the most common presenting symptom being a neck lump. Six out of eight patients underwent radioiodine therapy post-surgery, although there is no consensus on benefits for this. None of our patients were found to have metastases or nodal involvement. Our analysis adds to the current literature on this rare topic and will be important when discussing treatment options of this disease in the future and could help to narrow the gap towards a consensus for treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.